Reneo Pharmaceuticals, INC. (OKUR) — 10-K/A Filings
All 10-K/A filings from Reneo Pharmaceuticals, INC.. Browse 1 Amended Annual Report reports with AI-powered summaries and risk analysis.
10-K/A Filings (1)
-
Reneo Pharmaceuticals Files 10-K/A Amendment
— Apr 26, 2024 Risk: low
Reneo Pharmaceuticals, Inc. (OKUR) filed a Amended Annual Report (10-K/A) with the SEC on April 26, 2024. Reneo Pharmaceuticals, Inc. filed an amended 10-K repo
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX